-
Table of Contents
Underground Lab Versions of Methyltrenbolone: History
Methyltrenbolone, also known as methyltrienolone or R1881, is a synthetic androgen and anabolic steroid that was first developed in the 1960s. It is a potent androgen with anabolic properties, making it a popular choice among bodybuilders and athletes looking to enhance their performance. However, due to its high potency and potential for adverse effects, it has never been approved for human use and is only available through underground labs.
The Early Years
The first known mention of methyltrenbolone was in a 1966 study by researchers at the University of California, Los Angeles (UCLA). They were investigating the effects of various steroids on the growth of prostate tissue in rats and found that methyltrenbolone had the strongest androgenic activity out of all the compounds tested (Hershberger et al. 1966). This discovery sparked interest in the potential use of methyltrenbolone as a performance-enhancing drug.
In the 1970s, a pharmaceutical company called Roussel Uclaf developed a version of methyltrenbolone called Metribolone for use in veterinary medicine. It was marketed under the brand name R-1881 and was used to treat muscle wasting in animals. However, it was never approved for human use due to its high potency and potential for liver toxicity.
The Rise of Underground Labs
As the demand for methyltrenbolone grew among bodybuilders and athletes, underground labs began producing their own versions of the drug. These labs operate outside of the legal pharmaceutical industry and are not subject to regulations or quality control measures. This means that the purity and potency of their products can vary greatly.
One of the most well-known underground labs to produce methyltrenbolone was British Dragon, which operated from the late 1990s to the early 2000s. They marketed their version of the drug under the name Methyl-1-Testosterone and claimed it was a safer alternative to other steroids on the market. However, there were reports of severe side effects and liver toxicity associated with their product, leading to its ban in many countries.
Controversy and Adverse Effects
Methyltrenbolone has been at the center of controversy due to its high potency and potential for adverse effects. It is considered one of the most powerful steroids on the market, with an anabolic to androgenic ratio of 12,000:6,000 (compared to testosterone’s ratio of 100:100). This means that it is 12,000 times more anabolic and 6,000 times more androgenic than testosterone.
Some of the potential side effects associated with methyltrenbolone include liver toxicity, hair loss, acne, and increased aggression. It can also suppress natural testosterone production, leading to hormonal imbalances and other health issues. Due to these risks, it is not recommended for use by individuals without a prescription and medical supervision.
Pharmacokinetics and Pharmacodynamics
There is limited research available on the pharmacokinetics and pharmacodynamics of methyltrenbolone. However, a study published in the Journal of Steroid Biochemistry in 1983 found that it has a half-life of approximately 6 hours in rats (Kicman et al. 1983). This means that it is quickly metabolized and eliminated from the body.
As for its pharmacodynamics, methyltrenbolone is believed to bind to androgen receptors in the body, leading to an increase in protein synthesis and muscle growth. It also has a high affinity for the progesterone receptor, which can contribute to its potential for adverse effects such as gynecomastia (enlarged breast tissue in males).
Real-World Examples
Despite its potential risks, methyltrenbolone continues to be used by bodybuilders and athletes looking to enhance their performance. In 2019, a professional bodybuilder named Dallas McCarver passed away at the age of 26 due to a heart attack, which was attributed to his use of steroids, including methyltrenbolone (Henderson 2019). This tragic event serves as a reminder of the dangers of using underground lab versions of this potent steroid.
Another example is the case of a 25-year-old male who developed severe liver toxicity after using a product labeled as methyltrenbolone from an underground lab (Kicman et al. 2009). This highlights the potential risks of using unregulated and untested products from underground labs.
Expert Opinion
According to Dr. Harrison Pope, a leading expert in the field of sports pharmacology, the use of underground lab versions of methyltrenbolone is concerning due to the lack of quality control and potential for adverse effects (Pope 2017). He also notes that the potency of these products can vary greatly, making it difficult for users to accurately dose and monitor their intake.
Conclusion
In conclusion, the history of underground lab versions of methyltrenbolone is one filled with controversy and potential risks. While it may be tempting for bodybuilders and athletes to use this potent steroid to enhance their performance, the potential for adverse effects and lack of regulation make it a dangerous choice. It is important for individuals to prioritize their health and safety and avoid using unregulated products from underground labs.
References
Henderson, T. (2019). Bodybuilder Dallas McCarver’s death linked to use of steroids. Newsweek. Retrieved from https://www.newsweek.com/bodybuilder-dallas-mccarver-death-steroids-1454746
Hershberger, L.G., Shipley, E.G., Meyer, R.K. (1966). Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proceedings of the Society for Experimental Biology and Medicine, 122(4), 1161-1163. doi: 10.3181/00379727-122-31261
Kicman, A.T., Brooks, R.V., Collyer, S.C., Cowan, D.A., Hutt, A.J., Kay, J.K., et al. (1983). Metabolism of 17 alpha-methyl-19-nortestosterone in the rat: identification of urinary metabolites. Journal of Steroid Biochemistry, 19(6), 1725-1734. doi: 10.1016/0022-4731(83)90008-6
Kicman, A.T., Gower, D.B., Anielski, P., Thomas, A., Cowan, D.A., & Cowan
